摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-azido-2',5'-dideoxy-N4-benzoylcytidine | 74597-69-6

中文名称
——
中文别名
——
英文名称
5'-azido-2',5'-dideoxy-N4-benzoylcytidine
英文别名
5'-azido-N4-benzoyl-2',5'-dideoxycytidine;5'-azido-N4-benzoyl-2',5'-dideoxycytidine;5'-azido-N4-benzoyl-2',5'-dideoxy-cytidine;5'-Azido-N-benzoyl-2',5'-dideoxycytidine;N-[1-[(2R,4S,5R)-5-(azidomethyl)-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
5'-azido-2',5'-dideoxy-N<sup>4</sup>-benzoylcytidine化学式
CAS
74597-69-6
化学式
C16H16N6O4
mdl
——
分子量
356.341
InChiKey
OBDFXIWMWWPQSJ-OUCADQQQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    106
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5'-azido-2',5'-dideoxy-N4-benzoylcytidine 在 palladium on activated charcoal 吡啶氢气三乙胺 作用下, 以 乙醇溶剂黄146N,N-二甲基甲酰胺 为溶剂, 反应 25.0h, 生成 p-nitrophenyl N4-benzoyl-2',5'-dideoxy-5'-(4''-monomethoxytrityl)aminocytidine 3'-carbonate
    参考文献:
    名称:
    Uncharged stereoregular nucleic acid analogs. 1. Synthesis of a cytosine-containing oligomer with carbamate internucleoside linkages
    摘要:
    DOI:
    10.1021/jo00228a010
  • 作为产物:
    参考文献:
    名称:
    DNG cytidine: synthesis and binding properties of octameric guanidinium-linked deoxycytidine oligomer
    摘要:
    The synthesis of guanidinium-linked cytidyl oligomer (DNG-C-8), a cationic DNA analog, and the corresponding cytidine monomers is described. The DNG monomer synthesis was streamlined to produce a shorter route to the final monomer than previously reported for thymidine and subsequent solid-phase synthesis produced an octameric cytidyl DNG strand. Because octameric deoxyguanosine would be used as the complementary strand in our studies, it was necessary to investigate guanosine self-association. Singular value decomposition was used to mathematically deconvolve the spectral data and confirm the presence of transitions due to DNA-G(8) self-association. Job plots show the binding stoichiometry of DNG-C-8 with DNA-G(8) to be 1: 1. Thermal denaturation studies of the DNG-C-8-DNA-G(8) duplex established a T-m greater than or equal to 90degreesC and a DeltaGdegrees = 13.3 kcal mol(-1), indicating the DNG-C(8)(.)DNA-G(8) duplex is over 1000 times more stable than that of DNA-C(8)(.)DNA-G(8). (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.05.010
点击查看最新优质反应信息

文献信息

  • Template-Directed Synthesis in 3′- and 5′-Direction with Reversible Termination
    作者:Andreas Kaiser、Sebastian Spies、Tanja Lommel、Clemens Richert
    DOI:10.1002/anie.201203859
    日期:2012.8.13
    Extending both ways: A method for DNA‐templated synthesis on solid support is described. Controlled, stepwise chain extension was demonstrated both in the direction favored by nature (3′‐extension; see scheme) and in the direction typical for conventional DNA synthesizers (5′‐extension).
    两种方法都可以扩展:描述了一种在固相支持物上进行DNA模板合成的方法。在自然界偏爱的方向(3'-延伸;参见方案)和常规DNA合成仪的典型方向(5'-延伸)中都证明了可控的,逐步的链延伸。
  • Synthesis of dinucleotides containing a bridged non-chiral internucleotide 5′- or 3′-phosphoramidate linkage
    作者:Matthias Mag、Joachim W. Engels
    DOI:10.1016/s0040-4020(01)81755-5
    日期:1994.8
    The synthesis of several dinucleoside phosphate derivatives which are linked by phosphoramidate bonds [3′-O-P(O)(O−)-NH-5′ or 3′-NH-P(O)(O−)-O-5′] has been accomplished. The internucleoside phosphoramidate linkage was performed using the Staudinger reaction which is directly followed by a Michaelis-Arbuzov type transformation. Due to the exclusive use of base labile blocking groups deprotection could
    通过氨基磷酸酯键[ 3'- O - P(= O)(O -)- NH -5'或3'- NH - P(= O)(O -)- O连接的几种二核苷磷酸酯衍生物的合成-5′]已经完成。使用Staudinger反应进行核苷间氨基磷酸酯键合,然后直接进行Michaelis-Arbuzov型转化。由于仅使用碱不稳定的封闭基团,因此可以非常简单地通过在55°C下用浓氨水处理24小时来轻松进行脱保护。
  • 5′-modified nucleotides and the application thereof in molecular biology and medicine
    申请人:Europaisches Laboratorium fur Molekularbiologie (EMBL)
    公开号:US06627416B1
    公开(公告)日:2003-09-30
    The invention relates to 5′-modified nucleotides and to nucleic acids which contain these nucleotides. Processes for incorporating the 5′-modified nucleotides into nucleic acids, and the subsequent site-specific cleavage of the nucleic acids at the 5′-modified monomer building blocks, are also disclosed. These processes can be employed for nucleic acid sequencing, for generating nucleic acid libraries, for detecting mutations, for preparing support-bound nucleic acids and for pharmaceutical purposes.
    这项发明涉及5'-修饰核苷酸以及含有这些核苷酸的核酸。揭示了将5'-修饰核苷酸并入核酸中的过程,以及在5'-修饰单体构建块处对核酸进行后续的特异性切割。这些过程可用于核酸测序、生成核酸文库、检测突变、制备支持结合的核酸以及药物用途。
  • Yamamoto, Isamu; Sekine, Mitsuo; Hata, Tsujiaki, Journal of the Chemical Society. Perkin transactions I, 1980, p. 306 - 310
    作者:Yamamoto, Isamu、Sekine, Mitsuo、Hata, Tsujiaki
    DOI:——
    日期:——
  • SPROAT, BRIAN S.;BEIJER, BARBRO;RIDER, PETER, NUCL. ACIDS RES., 15,(1987) N 15, 6181-6196
    作者:SPROAT, BRIAN S.、BEIJER, BARBRO、RIDER, PETER
    DOI:——
    日期:——
查看更多

同类化合物

鲁西他滨 化合物 T14195 [1,1'-联苯基]-2,3,3',4,4',5'-六醇 [(2R,3R,5S)-3-(氨基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]N-[[(2R,3S,5R)-3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]氨基甲酸酯 9-(2-S-苯甲基-5-脱氧-2-硫代五呋喃糖基)-9H-嘌呤-6-胺 5-脱氧胸苷 5-脱氧-5-[(碘乙酰基)氨基]-胸腺嘧啶脱氧核苷 5-碘-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-2,5-二脱氧腺苷酸 5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷 5-三氟乙酰氨基-5-脱氧胸腺嘧啶脱氧核苷 5'-脱氧-5'氟胸苷 5'-脱氧-5'-{[4-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-{[3-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-[4-苯基-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(吡啶-3-基)-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(4-氟苯基)-(1,2,3)三唑-1-基]胸苷 5'-硫代-胸苷3',5'-二乙酸酯 5'-溴乙酰氨基-5'-脱氧胸苷 5'-氨基-5-碘-2',5'-二脱氧尿苷 2-氯-N-[[3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]乙酰胺 2,5-二脱氧腺苷 2',5'-二脱氧尿苷 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]嘧啶-2,4-二酮 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]-5-甲基嘧啶-2,4-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)嘧啶-2,4(1H,3H)-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)-5-碘嘧啶-2,4(1H,3H)-二酮 1-citosin-1-yl-1,2,5-trideoxy-α-L-threo-pentofuranos-4-yloxymethylphosphonic acid 9-[2,5-dideoxy-2-fluoro-5-[N-(N-2-hydroxybenzoyl)sulfamoyl]amino-β-D-ribofuranosyl]adenine triethylammonium salt 5'-amino-2',5'-dideoxy-2'-fuorouridine 1-(5'-deoxythymidin-5'-yl)-4-[methyloxycarbonyl-(2'-deoxy-2',2'-difluorocytidin-4N-yl)]-1H-1,2,3-triazole 2',5'-dideoxy-2'-(3,5-dimethoxybenzamido)-5'-(cyclohexylacetamido)adenosine 2',5'-dideoxy-2'-(3'',5''-dimethoxybenzamido)-5'-(diphenylacetamido)adenosine 2',5'-dideoxy-5'-(hydroxyethylthio)adenosine 1-(5-azido-2,5-dideoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyluracil 1-(5'-deoxythymidin-5'-yl)-4-[methyl-(2'-deoxy-2',2'-difluorocytidin-4N-yl)]-1H-1,2,3-triazole 4′-C-azidomethyl-2′-deoxy-2′-fluorouridine 2',5'-dideoxy-6-thioguanosine thymidylyl (3'-5') 5'-seleno-5'-deoxythymidine 3'-O-(t-butyldimethylsilyl)-4'-α-methylthymidine (E)- and (Z)-5-(2-bromovinyl)-1-(5-chloro-2,5-dideoxy-β-D-erythro-pentofuranosyl)-5-methyl-4-(1,2,4-triazol-1-yl)pyrimidin-2(1H)-one N-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranos-5-yl>succinamic acid N-butyl-N'-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranose-5-yl>maleamide N-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranos-5-yl>maleamic acid 4'-chloromethyl-2'-deoxy-2',2'-difluorocytidine 4'-chloromethyl-2'-deoxy-2'-fluoro-3'-O-(L-valinyl)cytidine dihydrochloride 5'-deoxy-5'-{4-[2-(3-oxo-3H-benzo[f]chromen-1-yl)acetamidomethyl]-1H-1,2,3-triazol-1-yl}thymidine N6-benzoyl-3'-O-t-butyldimethylsilyl-5'-sulfamoylazido-2',5'-dideoxyadenosine N-{9-[(2R,4S,5R)-5-(Acetylamino-methyl)-4-hydroxy-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide